|
March 31, 2012
|
|
DePuy Litigation: Statute of Limitations Depuy Lawsuits
|
|
In August of 2010 DePuy Orthopedics, Inc. recalled two of its most popular hip replacement systems—the ASR XL Acetabular and the ASR Hip Resurfacing System. The recall came on the heels of a study which indicated the five-year failure rate of these products was as high as one in every eight patients.
|
|
Full Story
|
|
|
|
|
February 05, 2012
|
|
Recall of Artificial Hip Causes Johnson & Johnson 2012 Earnings Forecast to Dip
|
|
The pharmaceutical giant, Johnson & Johnson, has been given a 2012 earnings forecast which is below the previous estimates present by financial analysts due to the number of DePuy hip replacements which were recalled. In fact, recent reports state Johnson & Johnson takes $3 billion charge for hip recall.
|
|
Full Story
|
|
|
|
|
February 04, 2012
|
|
Taking Charge: A Blueprint for DePuy Hip Implant Recipients to Follow for Successful Recovery
|
|
While the FDA began receiving complaints regarding the failure of hip replacement devices manufactured by DePuy Orthopedics (a subsidiary of Johnson & Johnson) for some time, there was not a DePuy hip extensive recall on the device until August of 2010.
|
|
Full Story
|
|
|
|